Evicenter
Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer
Manufacturer
Daiichi Sankyo, Inc.; AstraZeneca Pharmaceuticals LP
Prescribing information
Datroway (opens in a new tab)
Questions
42
Last updated

All questions

Pharmacology: Datroway (datopotamab deruxtecan-dlnk) in HR-positive HER2-negative breast cancer

4 questions · 2 sources

Mechanism

How does DATROWAY work (mechanism of action)?

Pharmacokinetics

How is DATROWAY metabolized?

What is the half-life of DATROWAY?

Components

What are the ingredients in DATROWAY?